Exhibit 10.1 THIRD AMENDMENT TO CONVERTIBLE SUBORDINATED PROMISSORY NOTES THIS THIRD AMENDMENT TO CONVERTIBLE SUBORDINATED PROMISSORY NOTES (this "Amendment") is made and entered into as of October 15, 2006 by and between Orion HealthCorp, Inc., a...Convertible Subordinated Promissory Notes • October 19th, 2006 • Orion Healthcorp Inc • Services-offices & clinics of doctors of medicine • Georgia
SECOND AMENDMENT TO CONVERTIBLE SUBORDINATED PROMISSORY NOTESConvertible Subordinated Promissory Notes • November 9th, 2006 • Orion Healthcorp Inc • Services-offices & clinics of doctors of medicine • Georgia
THIS SECOND AMENDMENT TO CONVERTIBLE SUBORDINATED PROMISSORY NOTES (this “Amendment”) is made and entered into as of August 8, 2006 by and between Orion HealthCorp, Inc., a Delaware corporation (the “Company”), and Brantley Partners IV, L.P. (“Payee”).
FIRST AMENDMENTConvertible Subordinated Promissory Notes • August 5th, 2016 • Lilis Energy, Inc. • Crude petroleum & natural gas • New York
THIS FIRST AMENDMENT TO THE CONVERTIBLE SUBORDINATED PROMISSORY NOTES (the “Amendment”), dated as of August 3, 2016, is entered into by LILIS ENERGY, INC., a Nevada corporation (the “Borrower”) and the holders listed on the signature pages hereto (each a “Lender” and collectively, the “Lenders”).
AMENDMENT NO. 1 TO THE CONVERTIBLE SUBORDINATED PROMISSORY NOTESConvertible Subordinated Promissory Notes • January 17th, 2012 • Ceres, Inc. • Agricultural production-crops • New York
This Amendment No. 1 (this “Amendment”) to the Convertible Subordinated Promissory Notes issued on August 1, 2011 to the holders and in the principal amounts set forth on Exhibit A hereto (as amended, the “Convertible Notes”), is made between Ceres, Inc., a Delaware corporation (the “Company”), and each of Rothschild Trust Guernsey Limited as Trustee F/B/O The Ambergate Trust (the “Trust”), Gimv N.V. (“Gimv”), Adviesbeheer Gimv Life Sciences 2004 N.V. (“Adviesbeheer”), Artal Luxembourg S.A. (“Artal”), H&Q Healthcare Investors (“H&Q Healthcare”), H&Q Life Sciences Investors (“H&Q Life Sciences”), Warburg Pincus Private Equity IX, L.P. (“Warburg Pincus”), The Kiley Revocable Trust (“Kiley”) and the Edmund and Ellen Olivier Revocable Family Trust (“Olivier”) (each of Trust, Gimv, Adviesbeheer, Artal, H&Q Healthcare, H&Q Life Sciences, Warburg Pincus, Kiley and Olivier are referred to herein individually as a “Noteholder” and, collectively, as the “Noteholders”).
